相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Case non-case studies: Principle, methods, bias and interpretation
Jean-Luc Faillie
THERAPIE (2019)
Chronic lymphocytic leukaemia
Michael Hallek et al.
LANCET (2018)
Lymphoma following clozapine exposure: More information needed
Jonathan G. Leung et al.
SCHIZOPHRENIA RESEARCH (2018)
Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population
K. van der Weide et al.
PHARMACOGENOMICS JOURNAL (2017)
Guidelines for the Pharmacotherapy of Schizophrenia in Adults
Gary Remington et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
International trends in clozapine use: a study in 17 countries
C. J. Bachmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Lymphoma developing during clozapine therapy
Michele Meltzer
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2016)
Human T Lymphocytes Bioactivate Heterocyclic Aromatic Amines by Forming DNA Adducts
Medjda Bellamri et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2016)
Epidemiology of chronic myeloid leukaemia: an update
Martin Hoglund et al.
ANNALS OF HEMATOLOGY (2015)
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2015)
Human bone marrow niche chemoprotection mediated by cytochrome p450 enzymes
Salvador Alonso et al.
ONCOTARGET (2015)
Patterns of clozapine and other antipsychotics prescriptions in patients with treatment-resistant schizophrenia in community mental health centers in Sao Paulo, Brazil
Ana Stella de Azevedo Silveira et al.
ARCHIVES OF CLINICAL PSYCHIATRY (2015)
Effect of Clozapine and Olanzapine on Neutrophil Kinetics: Implications for Drug-Induced Agranulocytosis
Winnie Ng et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Incidence of Cancer in Patients With Schizophrenia and Their First-Degree Relatives: A Population-Based Study in Sweden
Jianguang Ji et al.
SCHIZOPHRENIA BULLETIN (2013)
Monitoring product safety in the postmarketing environment
Robert G. Sharrar et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2013)
Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database
Francois Chavant et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
Jean-Louis Montastruc et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Detection and quantitation of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-Phenylimidazo[4,5-b]pyridine adducts in DNA using online column-switching liquid chromatography tandem mass spectrometry
Rajinder Singh et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Clozapine treatment associated with increased risk of acute myeloid leukemia (AML)
Jimmi Nielsen et al.
SCHIZOPHRENIA RESEARCH (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database
A. Bate et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Clozapine-induced agranulocytosis and its genetic determinants
Carolin Opgen-Rhein et al.
PHARMACOGENOMICS (2008)
Disproportionation of clozapine radical: A link between one-electron oxidation of clozapine and formation of its nitrenium cation
Adam Sikora et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Epidemiology of schizophrenia: Review of findings and myths
Erick L. Messias et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: A potential in vitro system for the study of agranulocytosis
Avril Pereira et al.
BIOCHEMICAL PHARMACOLOGY (2006)
NQO2 gene is associated with clozapine-induced agranulocytosis
O Ostrousky et al.
TISSUE ANTIGENS (2003)
Use of measures of disproportionality in pharmacovigilance - Three Dutch examples
ACG Egberts et al.
DRUG SAFETY (2002)
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
SJW Evans et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine
DP Williams et al.
MOLECULAR PHARMACOLOGY (2000)
分享论文
